These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 26029754)
1. HRT associated with modest risk increase in a relatively rare but serious cancer. Brown S Post Reprod Health; 2015 Mar; 21(1):7. PubMed ID: 26029754 [No Abstract] [Full Text] [Related]
3. Long-term use of estrogen-only hormone replacement therapy (HRT) linked with increased risk of ovarian cancer. American Medical Association Ginecol Obstet Mex; 2002 Aug; 70():409-10. PubMed ID: 12448047 [No Abstract] [Full Text] [Related]
4. Ovarian cancer and HRT in the Million Women Study. Narod SA Lancet; 2007 May; 369(9574):1667-8. PubMed ID: 17512836 [No Abstract] [Full Text] [Related]
5. Ovarian cancer and hormone replacement therapy. Gompel A; Plu-Bureau G Lancet; 2007 Sep; 370(9591):932; author reply 932-3. PubMed ID: 17869627 [No Abstract] [Full Text] [Related]
6. Hormone replacement therapy and risk of epithelial ovarian cancer. Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786 [TBL] [Abstract][Full Text] [Related]
7. Menopausal hormones and risk of ovarian cancer. Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062 [TBL] [Abstract][Full Text] [Related]
8. Relationship between postmenopausal hormone replacement therapy and ovarian cancer. Bosetti C; Negri E; Franceschi S; Trichopoulos D; Beral V; La Vecchia C JAMA; 2001 Jun; 285(24):3089; author reply 3090. PubMed ID: 11427129 [No Abstract] [Full Text] [Related]
9. Ovarian cancer and menopausal hormone therapy: more data and new questions. Lacey JV Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2524-5. PubMed ID: 18086754 [No Abstract] [Full Text] [Related]
10. Ovarian cancer patients and hormone replacement therapy: a systematic review. Hopkins ML; Fung MF; Le T; Shorr R Gynecol Oncol; 2004 Mar; 92(3):827-32. PubMed ID: 14984948 [TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk. Mills PK; Riordan DG; Cress RD; Goldsmith DF Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372 [TBL] [Abstract][Full Text] [Related]
12. What your doctor is reading. Hormone replacement therapy. Roberts SS Diabetes Self Manag; 2002; 19(6):78-81. PubMed ID: 12561772 [No Abstract] [Full Text] [Related]
13. Does HRT promote ovarian cancer? Health News; 2001 May; 7(5):8. PubMed ID: 11851163 [No Abstract] [Full Text] [Related]
14. Risks of hormone replacement therapy. Grant EC; Price EH; Steel CM Lancet; 1999 Oct; 354(9186):1302-3. PubMed ID: 10520664 [No Abstract] [Full Text] [Related]
15. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated]. Emons G; Westphalen S MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648 [TBL] [Abstract][Full Text] [Related]
16. Use of HRT and the subsequent risk of cancer. Beral V; Banks E; Reeves G; Appleby P J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959 [TBL] [Abstract][Full Text] [Related]
17. [Hormone replacement therapy: curse or blessing?]. Schmidt M; Fink D; Lang U; Kimmig R Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400 [TBL] [Abstract][Full Text] [Related]
18. [Cancer caused by menopausal hormone substitution in Germany. Results of calculating the attributed risk]. Greiser E Kinderkrankenschwester; 2004 Apr; 23(4):146-7. PubMed ID: 16134648 [No Abstract] [Full Text] [Related]